261 related articles for article (PubMed ID: 16616493)
1. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor.
Peschke B; Bak S; Hohlweg R; Nielsen R; Viuff D; Rimvall K
Bioorg Med Chem Lett; 2006 Jun; 16(12):3162-5. PubMed ID: 16616493
[TBL] [Abstract][Full Text] [Related]
2. 2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers.
Nikolakopoulos G; Figler H; Linden J; Scammells PJ
Bioorg Med Chem; 2006 Apr; 14(7):2358-65. PubMed ID: 16314104
[TBL] [Abstract][Full Text] [Related]
3. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
Ali SM; Tedford CE; Gregory R; Handley MK; Yates SL; Hirth WW; Phillips JG
J Med Chem; 1999 Mar; 42(5):903-9. PubMed ID: 10072687
[TBL] [Abstract][Full Text] [Related]
5. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
[TBL] [Abstract][Full Text] [Related]
6. D-amino acid homopiperazine amides: discovery of A-320436, a potent and selective non-imidazole histamine H(3)-receptor antagonist.
Curtis MP; Dwight W; Pratt J; Cowart M; Esbenshade TA; Krueger KM; Fox GB; Pan JB; Pagano TG; Hancock AA; Faghih R; Bennani YL
Arch Pharm (Weinheim); 2004 Apr; 337(4):219-29. PubMed ID: 15146898
[TBL] [Abstract][Full Text] [Related]
7. Cinnamic amides of (S)-2-(aminomethyl)pyrrolidines are potent H3 antagonists.
Peschke B; Bak S; Hohlweg R; Pettersson I; Refsgaard HH; Viuff D; Rimvall K
Bioorg Med Chem; 2004 May; 12(10):2603-16. PubMed ID: 15110842
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.
Faghih R; Dwight W; Pan JB; Fox GB; Krueger KM; Esbenshade TA; McVey JM; Marsh K; Bennani YL; Hancock AA
Bioorg Med Chem Lett; 2003 Apr; 13(7):1325-8. PubMed ID: 12657274
[TBL] [Abstract][Full Text] [Related]
9. First metal-containing histamine H3 receptor ligands.
Sander K; Kottke T; Hoffend C; Walter M; Weizel L; Camelin JC; Ligneau X; Schneider EH; Seifert R; Schwartz JC; Stark H
Org Lett; 2010 Jun; 12(11):2578-81. PubMed ID: 20446742
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor.
Fattori D; Porcelloni M; D'Andrea P; Catalioto RM; Ettorre A; Giuliani S; Marastoni E; Mauro S; Meini S; Rossi C; Altamura M; Maggi CA
J Med Chem; 2010 May; 53(10):4148-65. PubMed ID: 20408549
[TBL] [Abstract][Full Text] [Related]
11. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists.
Becknell NC; Lyons JA; Aimone LD; Huang Z; Gruner JA; Raddatz R; Hudkins RL
Bioorg Med Chem; 2012 Jun; 20(12):3880-6. PubMed ID: 22578490
[TBL] [Abstract][Full Text] [Related]
13. Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors.
Scarpelli R; Di Marco A; Ferrigno F; Laufer R; Marcucci I; Muraglia E; Ontoria JM; Rowley M; Serafini S; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2008 Dec; 18(23):6078-82. PubMed ID: 18952417
[TBL] [Abstract][Full Text] [Related]
14. Acidic elements in histamine H(3) receptor antagonists.
Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
[TBL] [Abstract][Full Text] [Related]
15. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial activity, and QSAR studies of furan-3-carboxamides.
Zanatta N; Alves SH; Coelho HS; Borchhardt DM; Machado P; Flores KM; da Silva FM; Spader TB; Santurio JM; Bonacorso HG; Martins MA
Bioorg Med Chem; 2007 Mar; 15(5):1947-58. PubMed ID: 17240153
[TBL] [Abstract][Full Text] [Related]
17. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Zaragoza F; Stephensen H; Peschke B; Rimvall K
J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025
[TBL] [Abstract][Full Text] [Related]
18. A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.
Apodaca R; Dvorak CA; Xiao W; Barbier AJ; Boggs JD; Wilson SJ; Lovenberg TW; Carruthers NI
J Med Chem; 2003 Aug; 46(18):3938-44. PubMed ID: 12930154
[TBL] [Abstract][Full Text] [Related]
19. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
